Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study
about
Clinical response in patients with ovarian cancer treated with metronomic chemotherapy.Metronomic cyclophosphamide-induced long-term remission after recurrent high-grade serous ovarian cancer: A case study.Whether low-dose metronomic oral cyclophosphamide improves the response to docetaxel in first-line treatment of non-triple-negative metastatic breast cancer.
P2860
Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Metronomic oral cyclophosphami ...... trospective, multicenter study
@ast
Metronomic oral cyclophosphami ...... trospective, multicenter study
@en
Metronomic oral cyclophosphami ...... trospective, multicenter study
@nl
type
label
Metronomic oral cyclophosphami ...... trospective, multicenter study
@ast
Metronomic oral cyclophosphami ...... trospective, multicenter study
@en
Metronomic oral cyclophosphami ...... trospective, multicenter study
@nl
prefLabel
Metronomic oral cyclophosphami ...... trospective, multicenter study
@ast
Metronomic oral cyclophosphami ...... trospective, multicenter study
@en
Metronomic oral cyclophosphami ...... trospective, multicenter study
@nl
P2093
P2860
P356
P1433
P1476
Metronomic oral cyclophosphami ...... trospective, multicenter study
@en
P2093
Alessia Di Legge
Antonella Savarese
Floriana Mascilini
Giacomo Corrado
Giovanni Scambia
Mariagrazia Distefano
Paola Malaguti
Riccardo Samaritani
Valeria Masciullo
P2860
P2888
P356
10.1186/1471-2407-14-947
P407
P50
P577
2014-12-13T00:00:00Z
P5875
P6179
1041203508